Intraductal papillary mucinous adenocarcinoma of the pancreas: Clinical outcomes, prognostic factors, and the role of adjuvant therapy

Gastrointestinal Cancer Research

Volumn 4, Issue 4, 2011, Pages 116-121

  Alexander, Brian M ^a   Castillo, Carlos Fernandez del ^b   Ryan, David P ^b   Kachnic, Lisa A ^b   Hezel, Aram F ^b   Niemierko, Andrzej ^b   Willett, Christopher G ^c   Kozak, Kevin R ^a   Blaszkowsky, Lawrence S ^b   Clark, Jeffrey W ^b   Warshaw, Andrew L ^b   Hong, Theodore S ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PROGNOSIS; RADIATION DOSE;

EID: 82055190013     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Conlon KC: Intraductal papillary mucinous tumors of the pancreas. J Clin Oncol 23:4518-4523, 2005
2. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al: Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 157:755-761, 2000
3. Moore PS, Orlandini S, Zamboni G, et al: Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 84:253-262, 2001
4. Sohn TA, Yeo CJ, Cameron JL, et al: Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788-797, 2004; discussion 97-99
5. Terris B, Blaveri E, Crnogorac-Jurcevic T, et al: Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160:1745-1754, 2002
6. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC: Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239:400-408, 2004
7. Rodriguez JR, Salvia R, Crippa S, et al: Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133:72-79, 2007
8. Salvia R, Fernandez-del Castillo C, Bassi C, et al: Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678-685, 2004
9. Wada K, Kozarek RA, Traverso LW: Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 189:632-636, 2005
10. Farrell JJ, Brugge WR: Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 55:701-714, 2002
11. Jang JY, Kim SW, Ahn YJ, et al: Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 12:124-132, 2005
12. Nakagohri T, Konishi M, Inoue K, Tanizawa Y, Kinoshita T: Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas. Hepatogastroenterology 51:1480-1483, 2004
13. Raut CP, Cleary KR, Staerkel GA, et al: Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13:582-594, 2006
14. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010, 1987
15. Kalser MH, Ellenberg SS: Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899-903, 1985
16. Klinkenbijl JH, Jeekel J, Sahmoud T, et al: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776-782, 1999
17. Neoptolemos JP, Stocken DD, Friess H, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210, 2004
18. Oettle H, Post S, Neuhaus P, et al: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267-277, 2007
19. Swartz MJ, Hsu CC, Pawlik TM, et al. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. Int J Radiat Oncol Biol Phys 76:839-844, 2010